MET Insurance · Financials · Global insurer · Retirement · Thesis updated August 11, 2026

MetLife posts high returns as it manages market drags

The company reported a 17 percent adjusted ROE in Q2 2026, reaching the top end of its target range.
MetLife held its direct expense ratio at 12.1 percent despite absorbing the PineBridge acquisition.
A new $3 billion share repurchase authorization was announced, which will support earnings per share.
Group Benefits mortality was exceptionally strong, but management expects about two points of this to normalize soon.
Weak private equity returns dragged down variable investment income in the second quarter.

01 Running thesis

Excellent execution despite market headwinds

MetLife reported a strong Q2 2026 that proved its New Frontier strategy is working. The company hit a 17 percent adjusted ROE and held its direct expense ratio at 12.1 percent, even while absorbing costs from the PineBridge acquisition. A newly announced $3 billion share repurchase authorization provides a strong floor for earnings per share.

Group Benefits performed exceptionally well, driven by a 79 percent mortality ratio. Meanwhile, the Retirement and Income Solutions segment offset a slow domestic pension market by writing over $1 billion in U.K. funded reinsurance. The company is finding growth in multiple regions and product lines.

However, the bear case is finding new traction in the investment portfolio. Private equity returns fell to 0.8 percent in the second quarter, heavily dragging down variable investment income. Management expects to gradually reduce private equity allocations in a higher interest rate environment, which could alter the long-term yield profile.

Investors will watch how quickly the favorable mortality rates normalize in the back half of the year. The company must also prove it can rotate its alternative investment portfolio without sacrificing yield, while completing its newly authorized $3 billion share buyback.

Aug 2026▲Q2 2026 proved excellent execution with a 17 percent ROE and a strict 12.1 percent expense ratio. Strong Group Benefits mortality helped offset weak private equity returns.

May 2026▲Q1 2026 strengthened the case. Adjusted EPS rose 23 percent, adjusted ROE reached 17 percent, and the direct expense ratio beat the full-year target.

Feb 2026▲The 2025 Form 10-K confirmed PineBridge closed and MIM became its own reportable segment. The open question moved from deal closing to lasting growth.

Nov 2025→The Q3 2025 filing kept the main strategy on track, but Latin America risk rose. Mexico VAT changes and Chile pension reform added clearer policy headwinds.

Nov 2025▲Group Benefits margins improved as management had guided, and RIS showed strong pension risk transfer momentum.

Aug 2025▼Q2 2025 earnings were weaker, with higher claims in Group Benefits and lower variable investment income.

02 Business model

Insurance float plus fee income

MetLife makes money by selling insurance and retirement products, then investing the premiums and account balances it receives. It also earns fees in asset management through MetLife Investment Management. The company serves large employers, retirement plan sponsors, individuals, and customers in international markets.

The New Frontier plan focuses on high returns and cost control. MetLife targets double-digit adjusted EPS growth, a 15 to 17 percent adjusted ROE, $25 billion of free cash flow over five years, and another 100 basis points of direct expense ratio improvement. The company aims for a 12.1 percent expense ratio target.

Retirement and Income Solutions relies on pension risk transfer, where companies pay MetLife to take over pension promises. Chariot Re, launched with an initial $10 billion reinsurance deal, gives MetLife another way to support retirement growth and create institutional assets for the asset management arm.

The model faces challenges when claims rise faster than pricing, private investments disappoint, currencies move unfavorably, or regulators change the rules. A balanced mix of capital-light and capital-heavy businesses helps cushion the downside.

03 Product portfolio

What MetLife sells

Cash cow

Group Benefits

MetLife sells life, dental, and non-medical health insurance through employers. This segment is highly profitable when mortality claims run low.

Growth engine

Retirement and Income Solutions

This group handles pension risk transfers and longevity reinsurance. It grows when employers decide to move pension liabilities off their own balance sheets.

Steady

Asia insurance

Asia sells life and accident and health products. The segment is a large earnings contributor, but reported results can move heavily with currency swings.

Steady

Latin America insurance

Latin America offers life and health products. The current issue is not underlying demand, but policy risk from regional tax and pension changes.

Growth engine

MetLife Investment Management

The asset management arm handles money for institutional clients. PineBridge added significant scale and global public and private credit capabilities.

Option

Chariot Re reinsurance

Chariot Re gives MetLife a platform for life and retirement reinsurance. It supports liability growth in the retirement business.

04 Business segments

Q2 earnings mix

Group Benefits29%modest

Asia24%modest

Retirement and Income Solutions22%modest

Latin America15%flat

EMEA6%modest

MetLife Investment Management4%growing fast

Segment shares use Q2 2026 adjusted earnings from operating segments only, excluding the Corporate and Other adjusted loss.

05 Risk factors

What could go wrong

Favorable mortality trends will normalize

Medium impact · High odds

Group Benefits saw an exceptionally low 79 percent mortality ratio in Q2 2026. Management warned that about two points of this benefit will normalize over the coming renewal cycles. As mortality claims return to historical averages, this earnings boost will fade.

We watchGroup Life mortality ratio in the next two quarters.

Weak private equity returns drag income

High impact · Medium odds

MetLife earns variable investment income from alternative assets. Private equity returns were very weak in Q2 2026, averaging only 0.8 percent. Extended periods of low alternative returns drag down overall portfolio yields and total earnings.

We watchVariable investment income and private equity average returns.

Latin America rules cut earnings

Medium impact · High odds

Mexico VAT changes are expected to reduce Latin America adjusted earnings by $50 million to $60 million in 2026. Chile pension reform also changes parts of the pension system, with the final impact still under review.

We watchMexico health repricing, Latin America adjusted earnings, and Chile pension reform regulations.

Currency pressure hides local growth

Medium impact · Medium odds

Asia and Latin America are important earnings sources, but results are reported in U.S. dollars. Foreign exchange volatility can make local growth look weaker in reported earnings, which pressures shareholder returns.

We watchReported versus constant-currency growth in Asia and Latin America.

06 Quick answers

In one breath

How does MetLife make money?

MetLife sells insurance and retirement products, then invests the money it receives. It also earns asset management fees through MetLife Investment Management.

Why did MetLife buy PineBridge?

PineBridge expanded MetLife Investment Management with more scale, products, and global distribution. MetLife is now focused on maintaining expense discipline and growing institutional assets.

What is pension risk transfer?

Pension risk transfer is when a company pays an insurer like MetLife to take over pension promises to workers or retirees. It can be attractive for MetLife if the price is right and the assets backing the promises perform well.

What is the biggest near-term risk for MetLife?

The main near-term risk is variable investment income swings from private equity and real estate, along with regulatory changes in Latin America.